Cargando…
Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia
Although mast cells (MC) play an important role in allergic reactions, their physiologic role remains unknown. In mice, several models of MC-deficiency have been developed. However, no comparable human model is available. We examined the in vitro- and in vivo effects of the KIT-targeting drug imatin...
Autores principales: | Cerny-Reiterer, Sabine, Rabenhorst, Anja, Stefanzl, Gabriele, Herndlhofer, Susanne, Hoermann, Gregor, Müllauer, Leonhard, Baumgartner, Sigrid, Beham-Schmid, Christine, Sperr, Wolfgang R, Mannhalter, Christine, Sill, Heinz, Linkesch, Werner, Arock, Michel, Hartmann, Karin, Valent, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413638/ https://www.ncbi.nlm.nih.gov/pubmed/25605011 |
Ejemplares similares
-
FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H()
por: Valent, Peter, et al.
Publicado: (2013) -
TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML
por: Valent, Peter, et al.
Publicado: (2017) -
Phenotyping and Target Expression Profiling of CD34(+)/CD38(−) and CD34(+)/CD38(+) Stem- and Progenitor cells in Acute Lymphoblastic Leukemia
por: Blatt, Katharina, et al.
Publicado: (2018) -
Identification of bromodomain-containing protein 4 (BRD4) as a novel marker and epigenetic target in mast cell leukemia
por: Wedeh, Ghaith, et al.
Publicado: (2015) -
Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasm
por: Füreder, Wolfgang, et al.
Publicado: (2016)